Markus Enzelberger Insider Profile
4 Followers
Markus Enzelberger, former Chief Scientific Officer at Morphosys, holds 1.68K shares in Morphosys (Ticker: GB:0NDV). Most recently, Markus Enzelberger Sold 1,837 shares of Morphosys on Nov 06, 2019 for an estimated value of €182.63K.
Markus Enzelberger's Trading History
| 0NDVMorphosys | Nov 06, 2019 | ― | Informative Sell | 182.63K | €113.30K | |||||||||||||||||||||||||||||||||||||||||||
GB:0NDV
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Markus Enzelberger insider profile FAQ
What is the percentage of profitable transactions made by Markus Enzelberger?
The percentage of profitable transactions made by Markus Enzelberger is 25%.
What is the average return per transaction made by Markus Enzelberger?
The average return per transaction made by Markus Enzelberger is -8.10%.
What stocks does Markus Enzelberger hold?
Markus Enzelberger holds: GB:0NDV stocks.
What was Markus Enzelberger’s latest transaction?
Markus Enzelberger’s latest transaction was an Informative Sell of €182.63K.
What was Markus Enzelberger's most profitable transaction?
Markus Enzelberger’s most profitable transaction was an Informative Sell of GB:0NDV stock on November 6, 2019. The return on the trade was 5.60%.
What is Markus Enzelberger's role in Morphosys?
Markus Enzelberger's role in Morphosys is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
